Latest News Archive
Please select Category, Year, and then Month to display items
07 March 2024
Photo Lunga Luthuli
Prof Francois Strydom, Senior Director at the Centre for Teaching and Learning and Simphiwe Kunene, the first African DREAM scholar and a master’s student from the Faculty of Education.
The University of the Free State (UFS) received recognition for its commitment to student success at the 2024 Achieving the Dream (ATD) conference which celebrated its 20-year anniversary. Simphiwe Kunene, an Education master's student originally from the Qwaqwa campus, was selected to represent South Africa as the first DREAM scholar from Africa as part of the conference.
The Achieving the Dream network of over 300 institutions, which is one of the largest movements in US higher education aims to transform colleges and universities so that students of colour and a lower socio-economic status are supported to earn a degree. The UFS is a leading partner in the Siyaphumelela Network, which has been working for 10 years with ATD to enhance the success of students in South Africa. Prof Francois Strydom, Senior Director at the Centre of Teaching and Learning (CTL), accepted the award on behalf of the institution.
Prof Strydom said that collaboration with the ATD and Siyaphumelela institutions has helped the UFS to develop cutting-edge approaches to “level the playing field” and support Kovsies to earn their undergraduate degrees.
The first African DREAM scholar
Kunene was selected as the first African DREAM scholar from the Siyaphumelela network. To select the DREAM scholar, each Siyaphumelela partner institution nominated one student as a preferred candidate. From the proposed candidates, the DREAM scholar was selected by the South African Institute for Distance Education (Saide) based on the following: demonstrating resilience, academic excellence, and a deep commitment to making a positive difference in universities and personal communities.
He addressed the conference of over 2 000 delegates and shared with them his hopes and dreams. Many members of the South African delegation said Simphiwe did his country proud. He had the following to say about his opportunity to be a DREAM scholar: “Being a DREAM scholar was life changing for me, exposing me to an array of opportunities I never knew were possible and available for me. It was as if, for a moment, the world had stopped to just listen to what I had to say."
The way forward
The UFS will continue its work as a partner of the Siyaphumelela network for the 2024-2026 cycle. The multi-stakeholder project team is focused on enhancing undergraduate students’ time, and to position the UFS as a thought and research leader in the area of student success as part of Vision 130.
UFS cardiac team leading with project
2017-05-31
Prof Peter Schultheiss of the Charité University in Berlin,
Germany, visited the Robert WM Frater Centre for
Cardiovascular Research at the UFS for a study regarding
cardiomyopathy, a significant cause of fatal heart failure
among Africans. From the left are Dr Glen Taylor,
Dr Danie Buys, Prof Makoali Makatoko,
Prof Schultheiss and Prof Francis Smit.
Photo: Rulanzen Martin
A team of cardiac doctors associated with the Robert WM Frater Cardiovascular Research Centre at the University of the Free State’s (UFS) Faculty of Health Sciences has commenced with a pioneering research project regarding idiopathic dilating cardiomyopathy.
An Afrocentric research focus
Prof Francis Smit, Head of the Department of Cardiothoracic Surgery at the UFS and Head of the Frater Centre, describes dilating cardiomyopathy as a heart muscle disease that is quite common, particularly among people of African descent. The disease weakens the heart muscle, which in turn leads to heart failure.
“To date there is no curable treatment for this condition and 50% of patients that have shown heart failure, died within a period of five years. The causes of this condition have been unknown in the majority of patients. But over the past few years major strides have been made where virus infections of the heart muscle or myocarditis have been identified as a possible underlying cause. Various genetic diseases are also linked to it,” says Prof Smit.
International collaborations ensure success
According to Prof Smit, the project is being run in conjunction with Prof Heinz-Peter Schultheiss of the Charité University and the Institute for Cardiac Diagnostics and Therapy in Berlin, Germany.
“We have been working on the project over the past 18 months and I have twice visited Prof Schultheiss in Germany. He is now visiting us in Bloemfontein. We have established a collaborative project focused on patients in central South Africa”.
Prof Schultheiss is a world leader regarding the diagnosis, pathology and treatment of dilating cardiomyopathy, says Prof Smit.
“He brings a lifetime of research experience to Bloemfontein and is internationally renowned as the father of myocardial or heart muscle biopsies.
“His pioneering work on the discipline has led to diagnostic accuracy that has induced purposeful and personalised treatment of dilating cardiomyopathy and has brought about dramatic changes in some subsets of patients’ life expectancy and their cure.”
Solving problems close to home
According to Prof Mokoali Makatoko, Head of the Department of Cardiology, there are more than 1500 new cases of heart failure identified annually at the Universitas Academic Hospital, of which approximately 30% are attributed to cardiomyopathy. “With the use of endomyocardial biopsies the team hopes to treat viruses unique to Southern Africa as well as other underlying causes of dilating cardiomyopathy.”
Prof Stephen Brown, Head of Paediatric Cardiology at the Universitas Academic Hospital, says children suffering from this disease never reach a mature age and those under his supervision will also be undergoing these tests. Various other departments at the UFS will also participate in this project. Profs Makatoko and Brown did the first four endomyocardial biopsies under the management of Prof Schultheiss during the past week. The results will be available in the coming weeks after which the project will be officially launched and patient recruitment will start in earnest.